Free Access
| Issue |
Med Sci (Paris)
Volume 36, Number 4, Avril 2020
|
|
|---|---|---|
| Page(s) | 319 - 322 | |
| Section | Le Magazine | |
| DOI | https://doi.org/10.1051/medsci/2020047 | |
| Published online | 01 May 2020 | |
- Wick W, Osswald M, Wick A, Winkler F. Treatment of glioblastoma in adults. Ther Adv Neurol Disord 2018 ; 11 : 1756286418790452. [CrossRef] [PubMed] [Google Scholar]
- Ribas A, Wolchok JD. Cancer immunotherapy using checkpoint blockade. Science 2018 ; 359 : 1350–1355. [Google Scholar]
- Hollingsworth RE, Jansen K. Turning the corner on therapeutic cancer vaccines. NPJ Vaccines 2019 ; 4 : 7. [CrossRef] [PubMed] [Google Scholar]
- Dutoit V, Migliorini D, Dietrich PY, Walker PR. Immunotherapy of malignant tumors in the brain: how different from other sites?. Front Oncol 2016 ; 6 : 256. [CrossRef] [PubMed] [Google Scholar]
- Migliorini D, Dutoit V, Allard M, et al. Phase I/II trial testing safety and immunogenicity of the multipeptide IMA950/poly-ICLC vaccine in newly diagnosed adult malignant astrocytoma patients. Neuro Oncol 2019 ; 21 : 923–933. [CrossRef] [PubMed] [Google Scholar]
- Schumacher T, Bunse L, Pusch S, et al. A vaccine targeting mutant IDH1 induces antitumour immunity. Nature 2014 ; 512 : 324–327. [Google Scholar]
- Chheda ZS, Kohanbash G, Okada K, et al. Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy. J Exp Med 2018 ; 215 : 141–157. [CrossRef] [PubMed] [Google Scholar]
- Keskin DB, Anandappa AJ, Sun J, et al. Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial. Nature 2019 ; 565 : 234–239. [Google Scholar]
- Hilf N, Kuttruff-Coqui S, Frenzel K, et al. Actively personalized vaccination trial for newly diagnosed glioblastoma. Nature 2019 ; 565 : 240–245. [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.